ABOUT NOVOTECH
Novotech is internationally recognized as the leading Asia Pacific-centered Biotech Contract Research Organization (CRO) with global execution capabilities.
Novotech is a clinical CRO with labs, phase I facilities, drug development consulting services, and FDA regulatory expertise and has experience in over 5,000 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. Novotech is positioned to serve biotech clients conducting clinical trials in Asia Pacific, the US, and Europe. Novotech has over 3000 staff globally and 34 office locations.
SERVICES
-
![novotech video snip thumb]( "The Asia Pacific Biotech CRO with Global Execution Capabilities")
Take advantage of the world’s fastest-growing clinical trials region to accelerate your global clinical development.
-
![Healthcare business graph data and growth, Stethoscope with doctor's health report clipboard on table]( "Biometrics And Data Management")
Delivering accurate, high-quality and timely biostatistics in clinical trials services, including statistical planning, analysis and reporting.
-
![Hand holding magnifier glass hiring recruit]( "Patient Recruitment And Site Selection")
Novotech relies on years of experience, in-country knowledge and real-life big data to identify and propose the best-performing sites for your study.
-
![The Consultant — Just Another Outsourced Provider]( "Novotech Medical And Regulatory Consulting")
Novotech’s Medical and Regulatory Consulting team offers full range of pre-clinical, regulatory affairs support, medical and pharmacovigilance consulting services.
-
![two-business-people-GettyImages-1354841430]( "Clinical Operations And Project Management For Every Phase")
Get streamlined and integrated clinical trial services delivered by a dedicated team of professionals with deep industry and therapeutic area expertise across all phases of clinical development.
WEBINARS
-
![novotech webinar snip thumb]( "Keeping Pace With The Evolving Global Landscape In Vaccine Development")
Hear from a panel of life science experts about the most recent developments and ground-breaking approaches shaping the field of vaccine development worldwide.
-
![novotech biotech]( "The Biotech Landscape: Market Trends, Priorities, Predictions, And Pathways To FDA Approval")
The webinar features regulatory affairs and investment leaders from North America and Asia Pacific who will discuss why biotech companies are increasingly exploring clinical opportunities in Asia Pacific to generate diverse, globally accepted clinical trial data, and much more.
-
![novotech 4]( "Go/No Go Decisions Based On Early Phase Oncology Trials")
In this webinar, gain insight into the latest regulatory and clinical developments in the field of oncology in China.
-
![novotech 3]( "Development And Regulatory Strategy For US And China")
This webinar discusses the expansion of International Market for Ensartini and RNAi Therapeutics in Oncology, from Skin Cancers to Liver Cancers.
-
![novotech 2]( "Accelerating Clinical Development In China & The US")
Discover how the clinical research bridge between China and the US supports accelerated clinical development from early to late phase trials while ensuring the inclusion of MRCT data packages in future regulatory applications.
-
![novotech 5]( "Evolution Of Cell & Gene Therapy In China: The Case For Universal CAR-T")
China now represents 60% of clinical development in CAR-T therapy development globally: what have we learned to date and where are future opportunities?
FEATURED REPORTS
-
![GettyImages-1387090964 cell and gene therapy]( "The Cell & Gene Therapy Clinical Trials Global Landscape")
Gain valuable insights into the current state of cell and gene therapy clinical trials and the opportunities and challenges in this rapidly evolving field.
-
![GettyImages-1441979374 clinical team]( "What Are The Benefits Of A Well-Designed, Robust Preclinical Development Plan?")
Discover how a well-designed and robust preclinical development plan can help identify potential safety and efficacy issues early in the drug development process, ultimately reducing the risk of failure in clinical trials.
-
![GettyImages-1362338827 IPF]( "Idiopathic Pulmonary Fibrosis: Global Clinical Trial Landscape - Focus On Asia Pacific")
Learn about the incidence, distribution, and possible control of idiopathic pulmonary fibrosis (IPF) in the Asia Pacific region, in addition to the standard of care, current trial landscape, and more.
-
![GettyImages-1442099826 Alzheimers]( "Alzheimer’s Disease: Global Clinical Trial Landscape - Focus On Asia Pacific")
Gain a better understanding of the incidence, distribution, and possible control of Alzheimer’s disease (AD) in the Asia Pacific region, the standard of care, the trial landscape, and more.
-
![GettyImages-1365972285 arthritis]( "Rheumatoid Arthritis: Global Clinical Trial Landscape - Focus On Asia Pacific")
Gain a better understanding of the incidence, distribution, and possible control of rheumatoid arthritis (RA) in the Asia Pacific region, the standard of care, the trial landscape, and more.
-
![GettyImages-1336788487 AML]( "Acute Myeloid Leukemia: Global Clinical Trial Landscape - Focus On Asia Pacific")
Gain a better understanding of the incidence, distribution, and possible control of acute myeloid leukemia (AML) in the Asia Pacific region, the standard of care, the trial landscape, and more.
-
![GettyImages-1365512998 prostate cancer]( "Prostate Cancer: Global Clinical Trial Landscape - Focus On Asia Pacific")
Better understand the incidence, distribution, and possible control of prostate cancer (PCa) in the Asia Pacific region, the standard of care, the trial landscape, and more.
-
![GettyImages-1394005450 breast cancer]( "Breast Cancer: Global Clinical Trial Landscape - Focus On Asia Pacific")
Better understand the incidence, distribution, and possible control of breast cancer in the Asia Pacific region, the standard of care, the trial landscape, and more.
-
![GettyImages-1437090427 melanoma]( "Melanoma: Global Clinical Trial Landscape - Focus On Asia Pacific")
Better understand the incidence, distribution, and possible control of melanoma in the Asia Pacific region, the standard of care, the trial landscape, and more.
-
![GettyImages-1394004470 ovarian cancer]( "Ovarian Cancer: Global Clinical Trial Landscape - Focus On Asia Pacific")
Better understand the incidence, distribution, and possible control of ovarian cancer (OC) in the Asia Pacific region, the standard of care, the trial landscape, and more.
-
![GettyImages-692413188 lab research]( "Why You Should Conduct Your Biotech And CAR-T Research In China")
China is leading the world in oncology and CAR-T research. And with over a billion people and a government friendly to biotech, it’s an ideal location for international clinical trials.
-
![GettyImages-851030650 global FDA]( "Designing A Global Drug Development Program To Secure FDA Approval")
Global clinical trials in the Asia-Pacific region are becoming an attractive solution for young biotech companies looking to utilize their capital efficiently and secure high-quality clinical data quickly.
-
![GettyImages-1222231706 global drug dev]( "Leveraging Global Drug Development Programs To Ensure Trial Success")
Opting to take your biotech program global can help save crucial resources, produce high-quality clinical data for your therapy, and leverage unique regional advantages like region-specific indication strategies.
-
![parkinson]( "Parkinson's Disease: Asia Pacific Clinical Trial Landscape")
In the coming years, the global burden of Parkinson's Disease (PD) is expected to rise. The number of people with PD in Asia is anticipated to exceed 6 million by 2030. Discover the factors leading to this in this report.
-
![Covid-GettyImages-1317211966]( "COVID-19: Asia Pacific Clinical Trial Landscape")
In December 2019, a novel coronavirus was discovered in China causing severe acute respiratory syndrome-like pneumonia which resulted in a pandemic. Find out more details regarding its spread in this report.
-
![Cancer-cells-GettyImages-996097236]( "Solid Tumors: Asia Pacific Clinical Trial Landscape")
Read more about how the large population and lower volume of studies decreases competing trial risk in this region with a great need for novel drug therapies for solid tumors in Asian patients
-
![Psoriasis Relief Handheld Device]( "Psoriasis: Asia Pacific Clinical Trial Landscape")
Psoriasis can have a significant psychological effect on both the patient and their family. Explore the cultural factors, socioeconomic factors, and higher levels of social stigma and prejudice resulting that make this disease more prevalent in Asia.
-
![Cell research GettyImages-879831370]( "Diffuse Large B-Cell Lymphoma: Asia Pacific Clinical Trial Landscape")
DLBCL is the most prevalent Non-Hodgkin Lymphoma (NHL) which accounts for about 30%-40% of all NHL cases worldwide. Explore its prevalence in the Asia Pacific region in this report.
-
![Asia iStock-1190455899]( "Clostridium Difficile Infection (CDI): Asia Pacific Clinical Trial Landscape")
Clostridium difficile infection is one of the leading causes of morbidity and mortality worldwide. Find out more about this disease in Asia, where a mean overall prevalence of nearly 15.0% was found among hospital patients.
-
![GettyImages-1385972198 liver]( "Non-Alcoholic Steatohepatitis (NASH): Asia Pacific Clinical Trial Landscape")
Even though NAFLD (non-alcoholic fatty liver disease) is a significant public health burden in the United States and Europe, learn why Asia has a NAFLD burden that is increasing faster than the developed countries of the West.
-
![GettyImages-1251251391 stomach]( "Ulcerative Colitis: The Asia Pacific Clinical Trial Landscape")
Find out how the incidence and prevalence of Ulcerative Colitis in Asia has rapidly increased over the past four decades with an incidence rate of around 6 cases per 100,000 population.
CONTACT INFORMATION
Novotech
235 Pyrmont Street, Level 3
Pyrmont, NSW 2009
AUSTRALIA
NEWS
- Novotech Acquires European CRO – Strengthens Global Operations
- Novotech Acquires US-based Drug Development Consulting Firm, CBR International: Expands Drug Development And FDA Regulatory Expertise
- Novotech Presented With Cell & Gene Excellence Award 2022 At 6th Cell & Gene Therapy World Asia Conference
FEATURED SOLUTIONS
CASE STUDIES
- From Phase I In Australia To A Global Phase III
- Study Launches Early Phase In Australia With Later Expansion To China
- Expert Consulting & Intelligent MRCT Strategy Rescues Oncology Program
- A Nimble And Flexible Solution To Rescuing An Observational Study
WHITE PAPERS
-
![GettyImages-1445640967 RNA therapy]( "RNA Therapies – Global Clinical Trial Landscape - Focus On Asia Pacific")
Learn about the global clinical trial landscape of RNA therapy, with emphasis on trends in the Asia Pacific, and recent advancements in the field.
-
![GettyImages-1293772957 clinical trials]( "Phase I Trials Global Clinical Trial Landscape – Focus On Asia Pacific")
Discover key trends in global Phase I trials, including highlights from the top therapeutic areas, indications, and biologic drug types in the last five-year period in popular trial regions of Asia Pacific, the United States, and Europe.
-
![GettyImages-1358868801 antibodies]( "Multi-Specific Monoclonal Antibodies – Global Clinical Trial Landscape - Focus On Asia Pacific")
Learn about the global clinical trial landscape of multi-specific monoclonal antibodies (Mabs), with emphasis on trends in the Asia Pacific, and recent advancements in the field.
-
![GettyImages-1207121866 bullseye]( "Capitalize On Regulatory Expertise To Simplify FDA Complexities")
Get an overview of the global approval landscape, pathways to approval, including typical impediments to success, and the importance of formulating a robust clinical development program as made possible with the help of an experienced and well-resourced CRO.
-
![GettyImages-1372859699 antibodies]( "Antibody Drug Conjugates: Global Clinical Trial Landscape - Focus On Asia Pacific")
Get a glimpse of the global clinical trial landscape of antibody drug conjugates (ADCs) and their trends in the Asia Pacific.
-
![eye-concept-iStock-1046702918]( "C3 Glomerulopathy: The Asia Pacific Clinical Trial Landscape")
C3 Glomerulopathy (C3G) is a complex, rare complement-mediated renal disease. Find out its effects in the Asia Pacific.
-
![only-diabetes]( "Diabetic Retinopathy: The Asia Pacific Clinical Trial Landscape")
Diabetic Retinopathy (DR) is the leading cause of vision loss in working-age populations, and one of the main complications of Diabetes Mellitus (DM). Read about the effects of this disease.
-
![Next Generation OCT Systems For Glaucoma Diagnosis]( "Opportunities For Ophthalmology Clinical Development In APAC: Glaucoma")
The world is heavily burdened by glaucoma, which is the second-leading cause of blindness and the primary cause of irreversible blindness. Learn about its effects in the Asia Pacific.
-
![Training Beyond Onboarding: Filling The Gaps In Food Manufacturing]( "Peanut Allergy: Asia Pacific Clinical Trial Landscape")
Explore the differences between the common food allergies in Asia and the West, specifically the peanut allergy.
-
![GettyImages-1135140461-lab-team]( "Paroxysmal Nocturnal HemoglobinuriaIn: The Asia Pacific Clinical Trial Landscape")
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare condition that affects the ability of hematopoietic stem cells and their cellular offspring to bind specific proteins to the cell surface.
-
![GettyImages-879828000-lab-cell-microscope]( "Top Therapeutic Areas In The Asia Pacific Clinical Trial Landscape")
Explore why the Asia-Pacific region has emerged as a clinical trial hub due to the ease of regulatory compliance, low trial costs, rising patient population, and the availability of top clinical institutions as trial locations
-
![GettyImages-1210301975-virus-analysis-cell-study]( "Cell & Gene Therapy In The Asia Pacific Clinical Trial Landscape")
Discover how a new class of therapeutics called cell and gene therapies are revolutionizing how diseases are treated and even potentially cured.
-
![China]( "The Biotech Landscape: Opportunities In China And The Path To USFDA Approval")
In this white paper, learn why western biopharma companies should take advantage of China’s revamped regulatory framework.
-
![fda]( "The Role Of Real World Evidence To Support US FDA And TGA Registrations")
Real world evidence (RWE) can contribute valuable information to new medicine registrations, in particular, for diseases that are difficult to assess in randomized clinical trials (RCTs) and for emerging technologies.
-
![Petri dishes with samples for DNA sequencing GettyImages-950425808]( "Next Generation Sequencing In The Asia Pacific: The Availability & Reimbursement Landscape")
Next generation sequencing (NGS) refers to a technology that detects genomic variation that is present at birth or emerges later in life. This report describes the availability of NGS in a selection of locations.
-
![GettyImages-1327568875-technology-clinical trials-computer-medicine-research]( "How Biotechs Are Using DCT Technology To Conduct Trials In The APAC Region")
In this white paper, gain insight into how the Asia Pacific region, with its rapid growth of clinical trials, presents a great opportunity for conducting clinical research and has become the preferred destination for DCTs.
-
![Oncology patient_cancer_hands]( "The Immuno-Oncology Clinical Trial Landscape In The Asia Pacific")
Learn how the Asia Pacific has shown significant increase in Immuno-oncology (IO) trials between 2017 and 2021 and contributes to about 35% of clinical development in IO globally.
-
![GettyImages-1209661942-lab-data-analysis-development]( "Clinical Development Strategies For Western Biotech Companies In China")
Delve into how China is now more aligned with international standards, enabling biotech firms to streamline processes and timelines, which has significantly recharged biotech innovation.
-
![Asia-iStock-1057495170]( "Evolution Of Clinical Trials In The Asia Pacific Region")
With changing global clinical trials landscape, explore how APAC is emerging as the hot spot for conducting clinical trials, especially in China.
